Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6
Open Access
- 4 December 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 159 (3), 292-302
- https://doi.org/10.1111/j.1365-2249.2009.04069.x
Abstract
The immunomodulatory ability of mesenchymal stem cells (MSCs) may be used to develop therapies for autoimmune diseases. Flk-1+ MSCs are a population of MSCs with defined phenotype and their safety has been evaluated in Phase 1 clinical trials. We designed this study to evaluate whether Flk-1+ MSCs conferred a therapeutic effect on collagen-induced arthritis (CIA), an animal model of rheumatic arthritis, and to explore the underlying mechanisms. Flk-1+ MSCs, 1–2 × 106, were injected into CIA mice on either day 0 or day 21. The clinical course of arthritis was monitored. Serum cytokine profile was determined by cytometric bead array kit or enzyme-linked immunosorbent assay. Flk-1+ MSCs and splenocytes co-culture was conducted to explore the underlying mechanisms. Flk-1+ MSCs did not confer therapeutic benefits. Clinical symptom scores and histological evaluation suggested aggravation of arthritis in mice treated with MSCs at day 21. Serum cytokine profile analysis showed marked interleukin (IL)-6 secretion immediately after MSC administration. Results of in vitro culture of splenocytes confirmed that the addition of Flk-1+ MSCs promoted splenocyte proliferation and increased IL-6 and IL-17 secretion. Moreover, splenocyte proliferation was also enhanced in mice treated with MSCs at day 21. Accordingly, MSCs at low concentrations were found to promote lipopolysaccharide-primed splenocytes proliferation in an in vitro co-culture system. We propose that Flk-1+ MSCs aggravate arthritis in CIA model by at least up-regulating secretion of IL-6, which favours Th17 differentiation. When Flk-1+ MSCs are used for patients, we should be cautious about subjects with rheumatoid arthritis.Keywords
This publication has 58 references indexed in Scilit:
- Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacitiesBlood, 2009
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+regulatory T cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in miceClinical and Experimental Immunology, 2008
- Effects of Human Mesenchymal Stem Cells on the Differentiation of Dendritic Cells from CD34+CellsStem Cells and Development, 2007
- Flk-1+Adipose-Derived Mesenchymal Stem Cells Differentiate into Skeletal Muscle Satellite Cells and Ameliorate Muscular Dystrophy in MDX MiceStem Cells and Development, 2007
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivoBiochemical and Biophysical Research Communications, 2005
- Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodiesInflammation Research, 1988
- Passive transfer studies with type II collagen antibody in b10.D2/old and new line and C57b1/6 normal and beige (chediak‐higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritisArthritis & Rheumatism, 1987